FDA Clearance Tracker · K143691
LDLC3 LDL-Cholesterol Gen.3
Last checked: Nov 20, 2026Latest source record: Jan 28, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Jan 28, 2015
Substantially Equivalent
Time to decision
35 days
Received Dec 24, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K143691
- Device name
- LDLC3 LDL-Cholesterol Gen.3
- Applicant
- Roche Diagnostics Operations (Rdo)
- Applicant location
- Indianapolis, IN
- Received
- Dec 24, 2014
- Decided
- Jan 28, 2015
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Ldl & Vldl Precipitation, Hdl (LBR)
- Device class
- Class I
- Regulation
- 21 CFR 862.1475
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LBR. The earliest in FDA's data is K780542, decided May 19, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K143691
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Roche Diagnostics Operations (Rdo)
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K193053 · Decided Mar 26, 2020 · 146 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
K192072 · Decided Feb 21, 2020 · 203 days after receipt
Device type: System, Test, C-Reactive Protein (DCN) · Laboratory Medicine & Pathology
- Ammonia II510(k)
K183517 · Decided Feb 8, 2019 · 52 days after receipt
Device type: Enzymatic Method, Ammonia (JIF) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.